Protalix BioTherapeutics
PLX
#8792
Rank
โ‚น14.70 B
Marketcap
โ‚น182.87
Share price
-2.69%
Change (1 day)
-8.96%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.83. In 2024 the company made an earnings per share (EPS) of โ‚น3.67 a decrease over its 2023 EPS that were of โ‚น11.00.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-52.41%
2024โ‚น3.67-66.67%
2023โ‚น11.00-138.71%
2022-โ‚น28.42-50%
2021-โ‚น56.83181.82%
2020-โ‚น20.17-82.11%
2019-โ‚น112.75-31.67%
2018-โ‚น165.00-72.31%
2017-โ‚น595.82124.14%
2016-โ‚น265.83-147.54%
2015โ‚น559.15-290.63%
2014-โ‚น293.326.67%
2013-โ‚น274.99130.77%
2012-โ‚น119.16-69.77%
2011-โ‚น394.1619.44%
2010-โ‚น329.99-12.2%
2009-โ‚น375.8236.67%
2008-โ‚น274.99-37.5%
2007-โ‚น439.9950%
2006-โ‚น293.323.23%
2005-โ‚น284.16138.46%
2004-โ‚น119.16-74%
2003-โ‚น458.32-0%
2002-โ‚น458.32-50%
2001-โ‚น916.64233.33%
2000-โ‚น274.99-84.21%
1999-โ‚น1,742-24%
1998-โ‚น2,292-600%
1997โ‚น458.32-16.67%
1996โ‚น549.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amicus Therapeutics
FOLD
-โ‚น10.08-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น395.07 21,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น157.66 8,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น57.75 3,050.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel